Intellectual Property India Publishes Patent Application for 'Quinazoline-Based Atr Kinase Inhibitors And A Process For Their Preparation' Filed by Indian Institute Of Technology

MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202421086843 A) filed by Indian Institute Of Technology, Gandhinagar, Gujarat, on Nov. 11, 2024, for 'quinazoline-based atr kinase inhibitors and a process for their preparation.'

Inventor(s) include Sivapriya Kirubakaran; and Pranav Umesh Bhagwat.

The application for the patent was published on Dec. 12, under issue no. 50/2025.

According to the abstract released by the Intellectual Property India: "The present disclosure relates to quinazoline derivatives and a process for their preparation. In particular, the present disclosure provides quinazoline-based ATR kinase inhibitors having reduced toxicity and better selectivity towards ATR Kinase for can...